Sign in
Stories
Waldencast's Accounting Scandal Unveiled
Share
AXT, Inc. Under Investigation
Abeona Therapeutics Investigated for Vio...
Activist Investor Targets Alight's Impro...
Fox Factory Faces Investor Lawsuit
Fox Factory Faces Securities Lawsuit
Fox Factory Facing Securities Lawsuit
Overview
API
Waldencast plc (NASDAQ: WALD) confronts accounting irregularities post its Obagi Skincare acquisition, causing CFO departure and SEC scrutiny. Overstated revenues lead to share price decline and suspicions of intentional financial misrepresentation.
Ask a question
How might Waldencast's accounting scandal impact investor trust and market confidence?
What measures can companies take to prevent and detect financial misstatements in acquisitions?
What regulatory changes could result from this incident to enhance financial transparency and accountability?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage